Bilski's Broad Sweep: Federal Circuit Says Vaccination Schedule Analysis Is Patentable

In Classen v. Biogen Idec the court rules that patents on a method of determining the administration schedule of vaccines are patent-eligible; the case applies the Supreme Court's Bilski decision on process patents to the biotech field.

More from Archive

More from Pink Sheet